AA
AVEO

Ancora Advisors’s AVEO Pharmaceuticals, Inc. AVEO Stock Holding History

Ancora Advisors’s Portfolio AVEO Stock Details AVEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-46,169
Closed -$380K – 2419
2022
Q3 		$380K Hold
46,169
– – 0.01% 562
2022
Q2 		$303K Hold
46,169
– – 0.01% 647
2022
Q1 		$258K Hold
46,169
– – 0.01% 727
2021
Q4 		$217K Hold
46,169
– – 0.01% 780
2021
Q3 		$285K Hold
46,169
– – 0.01% 689
2021
Q2 		$304K Buy
46,169
+5,819
+14% +$40.1K 0.01% 666
2021
Q1 		$295K Buy
40,350
+4,000
+11% +$34.5K 0.01% 640
2020
Q4 		$210K Hold
36,350
– – 0.01% 616
2020
Q3 		$216K Hold
36,350
– – 0.01% 594
2020
Q2 		$187K Buy
+36,350
New +$229K 0.01% 599

Other funds holding AVEO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NAM
Nexpoint Asset Management Dallas, Texas $1.49B AUM 61.08% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Man Group
Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
WIC
Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return

Ancora Advisors's AVEO Position: Q4 2022 in Review

Ancora Advisors sold out of AVEO Pharmaceuticals, Inc. (AVEO) in Q4 2022, closing a stake of 46,169 shares — an estimated $380K sold.

Ancora Advisors first reported a position in AVEO in Q2 2020 and held it in 10 quarters. The position peaked at $380K in Q3 2022. 110 funds tracked by Wall St. Rank hold AVEO as of Q4 2022.

  • Ancora Advisors reported no remaining AVEO Pharmaceuticals, Inc. position as of Q4 2022 after selling out during the quarter.
  • Ancora Advisors sold 46,169 AVEO Pharmaceuticals, Inc. shares in Q4 2022, an estimated $380K.
  • Ancora Advisors first reported a position in AVEO Pharmaceuticals, Inc. in Q2 2020 and held it in 10 quarters.
  • Ancora Advisors's AVEO Pharmaceuticals, Inc. position peaked at $380K in Q3 2022.
  • 110 funds tracked by Wall St. Rank held AVEO Pharmaceuticals, Inc. as of Q4 2022.

Based on Ancora Advisors's 13F filing for Q4 2022, filed 14 Feb 2023.